期刊文献+

肿瘤相关巨噬细胞在晚期卵巢癌组织中的浸润与肿瘤浸润淋巴细胞表型、免疫效能之间的关系 被引量:6

Relationship between invasion of tumor-associated macrophages and phenotype and immune efficacy of tumor-infiltrating lymphocytes in advanced ovarian carcinoma
下载PDF
导出
摘要 目的:探讨晚期卵巢癌组织中浸润的肿瘤相关巨噬细胞(tumor-associated macrophage,TAM)与肿瘤浸润淋巴细胞(tumor-infiltrating lymphocyte,TIL)表型及免疫效能的关系。方法:免疫组化方法分析175例低分化卵巢癌组织病理切片中TAM分布密度,以中位数为界限将病例分为TAM高密度组和TAM低密度组,对照组为32例良性卵巢病变组织;应用流式细胞术分析TAM高密度组与TAM低密度组中TIL的CD8+和CD25+表型变化情况;体外扩增培养TIL后取细胞培养上清液,ELISA法分析各组TIL中白细胞介素2(IL-2)、白细胞介素-10(IL-10)、转化生长因子β(TGF-β)和干扰素γ(IFN-γ)细胞因子表达变化。结果:175例低分化卵巢癌组织中TAM平均浸润密度为62.8/高倍镜视野(HP,×400),中位数为53.3/HP,其中TAM高密度组87例,TAM低密度组88例;对照组TAM平均浸润密度10.5/HP(P<0.05)。CD8+在TAM高密度组中表达平均值为24%,在TAM低密度组中表达平均值为52%(P<0.05);CD25+在TAM高密度组中表达平均值为48%,在TAM低密度组中表达平均值为25%(P<0.05);对照组中CD8+和CD25+的TIL平均浸润密度为7%,TAM高密度组及TAM低密度组中CD8+和CD25+的TIL平均浸润密度显著高于对照组(P<0.05)。与TAM低密度组比较,TAM高密度组中TIL的杀伤性细胞因子IL-2和IFN-γ表达明显减少(P<0.05),而抑制性细胞因子IL-10和TGF-β表达明显增加(P<0.05)。结论:高密度TAM浸润的卵巢癌组织中,CD25+的TIL表型增多,CD8+的TIL表型减少,抑制性细胞因子IL-10和TGF-β表达增加,杀伤性细胞因子IL-2和IFN-γ表达减少,提示TAM浸润密度与TIL表型及免疫效能相关。 AIM:To explore the relationship between the invasion of tumor-associated macrophages(TAM) and the phenotype and immune efficacy of tumor-infiltrating lymphocytes(TIL) in advanced ovarian carcinoma. METHODS:Immunohistochemical analysis of TAM density in 175 cases of poorly-differentiated ovarian cancer tissue biopsy was performed. The cases were divided into TAM high-density(TAMHigh) group and TAM low-density(TAMLow) group according to the median of TAM density. The control group included 32 cases of benign ovarian lesions. The changes of CD8+ and CD25+ phenotypes of TIL were detected by flow cytometry analysis. TIL in the 2 groups were cultured in vitro and the conditioned-medium was collected for detecting the expression of IL-2, IL-10, TGF-β and IFN-γ by ELISA. RESULTS:The average TAM infiltration density was 62.8/high-power field(HP, ×400) in 175 cases of poorly-differentiated ovarian carcinoma, and the median was 53.3/HP. TAMHigh group was 87 cases and TAMLow group was 88 cases. A significant difference between malignant ovarian carcinoma group and control group(10.5/HP) was observed. The mean expression of CD8+ TIL in TAMHigh group was 24%, and CD8+ TIL in TAMLow group was 52%(P〈0.05). The mean expression of CD25+ TIL in TAMHigh was 48%, and CD25+ TIL in TAMLow was 25%(P〈0.05). The average infiltration density of CD8+ and CD25+ TIL in control group was 7%. The average infiltration density of CD8+ and CD25+ TIL in TAMHigh and TAMLow groups was significantly higher than that in control group(P〈0.05). Compared with TAMLow group, TIL destruction cytokines IL-2 and IFN-γ were significantly decreased in TAMHigh group(P〈0.05), while the inhibitory cytokines IL-10 and TGF-β were significantly increased(P〈0.05). CONCLUSION:In high-density TAM infiltration of ovarian cancer tissues, CD25+ TIL type and inhibitory cytokines IL-10 and TGF-β increase, while CD8+ TIL type and destruction cytokines IL-2/IFN-γ decrease, suggesting that the high-density TAM has relationship with the phenotype and immune efficacy of TIL.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2012年第9期1618-1622,共5页 Chinese Journal of Pathophysiology
基金 广东省科技计划项目(No.2010B031600313)
关键词 肿瘤相关巨噬细胞 肿瘤浸润淋巴细胞 卵巢肿瘤 肿瘤逃逸 Tumor-associated macrophages Tumor-infiltrating lymphocytes Ovarian neoplasms Tumor escape
  • 相关文献

参考文献13

  • 1秦迎松,冯盼盼,李俐.基质胶原蛋白降解产物参与瘤内浸润淋巴细胞的趋化[J].中国病理生理杂志,2010,26(A10):2019-2019. 被引量:1
  • 2李彪如,沈鼎鸿.肿瘤浸润淋巴细胞生物学性状初步研究[J].中华微生物学和免疫学杂志,1994,14(6):399-402. 被引量:4
  • 3Van Ravenswaay Claasen HH, Kluin PM, Fleuren GJ. Tumor infiltrating cell in human cancer. On the possible role of CD16 macrophage in antitumor cytotoxity [ J ].Lab Invest, 1992, 67 (2) : 166 - 174.
  • 4Tanaka Y, Kobayashi H, Suzuki M, et al. Thymidine phosphorylase expression in tumor- infiltrating maeropha- ges may be correlated with poor prognosis in uterine endo- metrial cancer[ J ]. Hum Pathol, 2002, 33 ( 11 ) : 1105 - 1113.
  • 5Takanami I, Takeuchi K, Kodaira S, et al. Tumor - asso- ciated macrophage infiltration in pulmonary adenocarcino- ma: association with angiogenesis and poor prognosis [ J ]. Oncology,1999, 57(2) :138 - 142.
  • 6万挺,刘继红,郑利民,蔡木炎,丁童.肿瘤相关巨噬细胞在晚期上皮性卵巢癌组织中的浸润及其与预后的关系[J].癌症,2009,28(3):323-327. 被引量:24
  • 7Nagaraj S, Gupta K, Pisarev V, et al. Altered recognition of antigen is a mechanism of CD8 T cell tolerance in cancer[J]. Nat Med, 2007, 13(7) : 828 -835.
  • 8Hoechst B, Ormandy LA, Ballmaier M, et al. A new pop- ulation of myeloid - derived suppressor cells in hepatocel: lular carcinoma patients induces CIM CD25 Foxp3 T cells[J]. Gastroenterology, 2008, 135(1): 234-243.
  • 9Lesokhin AM, Hohl TM, Kitano S, et al. Monocytic CCR2 myeloid- derived suppressor cells promote im- mune escape by limiting activated CD8 T- cell infiltration into the tumor microenvironment [ J ]. Cancer Res, 2012, 72(4) : 876 -886.
  • 10Kim S, Buchlis G, Fridlender ZG, et al. Systemic block- ade of transforming growth factor - 13 signaling augments the efficacy of immunogene therapy [ J ]. Cancer Res, 2008, 68(24) : 10247 - 10256.

二级参考文献20

  • 1宋宇峰,冯红超,温玉明.口腔鳞状细胞癌中巨噬细胞浸润和肿瘤生长、转移的关系[J].中华口腔医学杂志,2005,40(5):385-385. 被引量:9
  • 2彭娟,丁童,郑利民,邵建永.肿瘤相关巨噬细胞对鼻咽癌进展和预后的影响[J].癌症,2006,25(11):1340-1345. 被引量:17
  • 3Van Ravenswaay Claasen HH, Kluin PM, Fleuren GJ. Tumor infiltrating cell in human cancer, on the possible role of CD16+ macrophage in antitumor cytotoxity [J]. Lab Invest, 1992,67(2) : 166-174.
  • 4Van Netten JP, George EJ, Ashmead BJ, et al. Macrophagetumour cell associations in breast cancer [J]. Lancet, 1993, 342(8875 ) : 872-873.
  • 5Takanami I, Takeuchi K, Kodaira S. Tumor-associated macrophage infiltration in pulmonary adenocarcinoma:association with angiogenesis and poor prognosis [J]. Oncology, 1999,57(2) : 138-142.
  • 6Lindsay TH, Jonas BM, Sevcik MA, et al. Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression [J ]. Pain, 2005,119(1-3) : 233-246.
  • 7Wang X, Deavers M, Patenia R, et al. Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease [J]. J Transl Med, 2006,4 (30): 1-11.
  • 8Melichar B, Savary CA, Patenia R. Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma [J]. Int J Gynecol Cancer, 2003,13(4) :435-443.
  • 9Gordon IO, Freedman RS. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients [J]. Clin Cancer Res, 2006,12(5) : 1515-1524.
  • 10Mosser DM. The many faces of macrophage activation [J]. J Leukoc Biol, 2003,73 (2) : 209-212.

共引文献26

同被引文献50

  • 1韦佩佳.老年复发卵巢癌患者预后影响因素[J].中国老年学杂志,2014,34(8):2081-2082. 被引量:10
  • 2Mantovani A, Biswas SK, Galdiero MR, et al. Macrophage plas- ticity and polarization in lissue repair and remodelling. J Pathol,2013, 229(2) : 176-185.
  • 3Singh M, Del Carpio-Cano F, Belcher JY, et al. Functional rolesof osteoactivin in normal and disease processes. Crit Rev EukaryotGene Expr,2010,20(4) ; 341-357.
  • 4Ripoll VM,Irvine KM, Ravasi T, et al. Gpnmb is induced inmacrophages by IFN-gamma and lipopolysaccharide and acts as afeedback regulator of proinflammatory responses. J Immunol,2007, 178(10) : 6557-6566.
  • 5Chung JS,Bonkobara M,Tomihari M,et al. The DC-HIL/synde-can-4 pathway inhibits human allogeneic T-cell responses. Eur JImmunol, 2009,39(4) : 965-974.
  • 6Crowder CW, Murphy WJ,Russell SW,et al. Interaction with ve-sicular stomatitis virus-infected BALB/c3T3 cells inhibits the syn-thesis of nitric oxide in activated murine bone marrow culture-de-rived macrophages. J Leukoc Biol, 1999,65(5) : 605-613.
  • 7Ichioka M, Suganami T,Tsuda N, et al. Increased expression ofmacrophage-inducible C-type lectin in adipose tissue of obese miceand humans. Diabetes, 2011, 60(3) : 819-826.
  • 8Biswas SK, Chittezhath M, Shalova IN, et al. Macrophage polari-zation and plasticity in health and disease. Immunol Res, 2012,53(1-3): 11-24.
  • 9Weterman MA, Ajubi N, van Dinter IM, et al. nmb, a novelgene, is expressed in low-metastatic human melanoma cell linesand xenografts. Int J Cancer, 1995 , 60( 1 ) ; 73-81.
  • 10Pahl MV, Vaziri ND, Yuan J, et al. Upregulation of monocyte/macrophage HGFIN ( Gpnmb/Osteoactivin) expression in end-stage renal disease. Clin J Am Soc Nephrol,2010,5(1): 56-61.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部